Mesa Laboratories, Inc.
MLAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $514,912 | $644,205 | $715,922 |
| - Cash | $20,422 | $21,279 | $27,321 | $30,956 |
| + Debt | $106,000 | $184,936 | $181,472 | $211,612 |
| Enterprise Value | – | $678,569 | $798,356 | $896,578 |
| Revenue | $60,737 | $59,543 | $62,135 | $62,840 |
| % Growth | 2% | -4.2% | -1.1% | – |
| Gross Profit | $37,331 | $32,494 | $38,412 | $39,754 |
| % Margin | 61.5% | 54.6% | 61.8% | 63.3% |
| EBITDA | $10,710 | $15,167 | $10,477 | $6,122 |
| % Margin | 17.6% | 25.5% | 16.9% | 9.7% |
| Net Income | $2,476 | $4,742 | -$7,114 | -$1,676 |
| % Margin | 4.1% | 8% | -11.4% | -2.7% |
| EPS Diluted | 0.45 | 0.85 | -1.31 | -0.31 |
| % Growth | -47.1% | 164.9% | -322.6% | – |
| Operating Cash Flow | $8,222 | $1,893 | $12,665 | $18,439 |
| Capital Expenditures | -$1,092 | -$1,009 | -$1,007 | -$813 |
| Free Cash Flow | $7,130 | $884 | $11,658 | $17,626 |